MedPath
Found 4 clinical trials|View Analysis
Sort by:

Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer

Phase 1
Conditions
Metastatic Castrate-Resistant Prostate Cancer
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Interventions
Drug: XNW5004
Drug: enzalutamide
First Posted Date
2024-11-25
Last Posted Date
2024-11-25
Lead Sponsor
Evopoint Biosciences Inc.
Target Recruit Count
307
Registration Number
NCT06702995
Locations
🇨🇳

Cancer Hosipital of Shandong First Medical University,440 Jiyan Road, Jinan City, Shandong Province, Jinan, Shandong, China

🇨🇳

270 Dongan Road, Shanghai, Shanghai, Shanghai, China

To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

Phase 2
Not yet recruiting
Conditions
Relapsed/Refractory Peripheral T Cell Lymphoma
Interventions
Drug: XNW5004 tablets
First Posted Date
2024-11-25
Last Posted Date
2024-11-25
Lead Sponsor
Evopoint Biosciences Inc.
Target Recruit Count
50
Registration Number
NCT06702605

To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors

Phase 1
Recruiting
Conditions
Advanced Tumor
Lymphoma
Interventions
Drug: XNW5004 tablets
First Posted Date
2024-08-16
Last Posted Date
2024-08-16
Lead Sponsor
Evopoint Biosciences Inc.
Target Recruit Count
176
Registration Number
NCT06558513
Locations
🇨🇳

Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)

Phase 1
Recruiting
Conditions
Carcinoma
Urothelial Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-small Cell Lung Cancer
Prostate Cancer
Cervical Cancer
Other Solid Tumors
Small-cell Lung Cancer
Interventions
First Posted Date
2023-09-05
Last Posted Date
2024-02-23
Lead Sponsor
Evopoint Biosciences Inc.
Target Recruit Count
204
Registration Number
NCT06022757
Locations
🇨🇳

Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, Guodong Province, China

© Copyright 2025. All Rights Reserved by MedPath